Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study examines mastectomy and breast-conserving surgery rates

14.10.2009
Breast–conserving surgery offered to the majority of patients

There is concern that mastectomy is over-utilized in the United States, which raises questions about the role of surgeons and patient preference in treatment selection for breast cancer.

New data from an observational study found that breast-conserving surgery was presented and provided in the majority of patients evaluated. Surgeon recommendations, patient decisions, and failure of breast-conserving surgery were all found to be contributing factors to the mastectomy rate. The findings are published in the October 14 issue of the Journal of the American Medical Association (JAMA), a theme issue on surgical care.

The study was lead by Monica Morrow MD, Chief of the Breast Service in the Department of Surgery at Memorial Sloan-Kettering Cancer Center, along with Steven Katz MD, MPH, and colleagues at the University of Michigan Comprehensive Cancer Center. Dr. Morrow and colleagues were interested in investigating the factors responsible for the overall mastectomy rate in the United States and why women undergo mastectomy for the initial treatment of breast cancer.

The findings suggest that surgeons are appropriately recommending breast-conserving surgery and that patient preferences play an important role in shaping the pattern of surgical treatment for breast cancer, especially in the absence of a surgeon recommendation favoring one procedure over another. This is consistent with previous studies performed by these investigators that have shown that when both procedures are medically appropriate, increased patient involvement in breast surgery decisions is associated with greater probability of mastectomy. In this study, one-third of patients appear to choose mastectomy as initial treatment when not given a specific recommendation for mastectomy by their surgeons. Researchers speculate that patients may prefer mastectomy for "peace of mind" or to avoid radiation and are often strongly influenced by concerns about disease recurrence and fear. "Women need to understand that although it intuitively seems obvious that a bigger surgery is a better surgery-it may not be the case here. There are some patients for whom mastectomy is the best medical treatment, but when it is not indicated, women need to make sure that if they are choosing mastectomy as a matter of preference that they understand that it is not going to improve the likelihood of breast cancer survival. The risk of cancer recurring in the breast after a lumpectomy is basically no different than the risk of cancer recurring in the scar tissue of a mastectomy," said Dr. Morrow.

Concerns about the excessive use of mastectomy for patients with breast cancer have been raised for decades despite a marked increase in breast-conserving surgery in recent years. According to a 2008 study (by the Mayo Clinic), mastectomy rates were 45 percent in 1997, dropped to 30 percent in 2003, but then increased to 43 percent in 2006.

In this new study, Dr. Morrow and colleagues found that of 1984 women aged 20 to 79 years with stage 1 and 2 breast cancer that was diagnosed between June,2005 and February,2007: 67 percent of women reported that their first surgeon recommended breast-conserving surgery and that they had successful procedures; 13 percent had mastectomies after initial surgical recommendation; 8.8 percent had mastectomies when there was no clear surgical recommendation for either procedure; and finally, an additional 8.8 percent reported having unsuccessful breast-conserving surgery that required revision with mastectomy. The results are based on data reported to the metropolitan Los Angeles and Detroit Surveillance, Epidemiology and End Results (SEER) registries.

"Our results and those from other studies we performed suggest that surgeons face special challenges in how they discuss treatment options and elicit the treatment preferences of their patients with breast cancer. Our results reinforce that both patient preferences and surgeon recommendations are powerful determinants of treatment," said Dr. Katz, who is a professor of internal medicine and health management and policy at the University of Michigan.

"This study suggests that breast-conserving surgery has been appropriately adopted by surgeons and for most women- if they are given a specific reason why they are not a good candidate for breast-conserving surgery, a second opinion is not likely to change that," said Dr. Morrow.

Funding for this study was provided by grants from the National Cancer Institute and the American Cancer Society to the University of Michigan. Dr. Katz was supported by an Established Investigator Award in Cancer Prevention, Control, Behavioral, and Population Sciences Research from the NCI.

Memorial Sloan-Kettering Cancer Center is the world's oldest and largest private institution devoted to prevention, patient care, research, and education in cancer. Our scientists and clinicians generate innovative approaches to better understand, diagnose, and treat cancer. Our specialists are leaders in biomedical research and in translating the latest research to advance the standard of cancer care worldwide.

Jeanne D'Agostino | EurekAlert!
Further information:
http://www.mskcc.org

More articles from Studies and Analyses:

nachricht Multi-year study finds 'hotspots' of ammonia over world's major agricultural areas
17.03.2017 | University of Maryland

nachricht Diabetes Drug May Improve Bone Fat-induced Defects of Fracture Healing
17.03.2017 | Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Researchers shoot for success with simulations of laser pulse-material interactions

29.03.2017 | Materials Sciences

Igniting a solar flare in the corona with lower-atmosphere kindling

29.03.2017 | Physics and Astronomy

As sea level rises, much of Honolulu and Waikiki vulnerable to groundwater inundation

29.03.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>